• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is Elevance Health (ELV) Still Undervalued Following Strong Earnings And Higher 2026 Guidance?

    Simply Wall St·10/25/2026 08:30:42
    Listen to the news

    Why Elevance Health’s Latest Earnings Matter For Investors

    Elevance Health (ELV) just put fresh numbers on the table. Third quarter results, updated 2026 earnings guidance and segment level progress in CarelonRx are now shaping how investors think about the stock.

    Elevance Health’s recent earnings update and raised 2026 guidance come on top of strong price momentum, with a 30 day share price return of 11.07% and a 90 day gain of 16.28%, while the 1 year total shareholder return of 31.06% reflects both capital gains and dividends, supported by the latest dividend affirmation and the leadership change at Carelon.

    Scan how Elevance Health compares with other healthcare stocks showing strong fundamentals and fresh momentum by reviewing the hand picked 29 high quality undervalued stocks.

    After a sharp move and higher guidance from Elevance Health, the real tension now is simple: Is the meaningful upside still in front of you, or has this run already priced most of it in?

    Most Popular Narrative: 7% Undervalued

    Elevance Health last closed at $439.95, while the most followed narrative pegs fair value closer to $474.57 using a 7.28% discount rate. That gap frames the current debate around whether recent earnings strength and Carelon execution justify a higher valuation over time.

    Ongoing deployment of Elevance Health’s AI, analytics and digital platforms such as HealthOS and Sydney Health, including automated prior authorization and earlier visibility into medical cost trends, is expected to tighten medical cost management and support more stable net margins and earnings over time.

    See why 116 investors see Elevance Health as 7% undervalued.

    Result: Fair Value of $474.57 (UNDERVALUED)

    Still, the story around Elevance Health can change if Medicaid margins stay pressured or if medical cost trends in ACA and commercial plans keep grinding higher.

    Find out about the key risks to this Elevance Health narrative.

    Next Steps

    Mixed feelings about Elevance Health after this update are healthy, so move fast, review the data points yourself, and weigh both the encouraging signals and the issues that still worry investors with the help of 4 key rewards and 1 important warning sign.

    Looking For More Investment Ideas Beyond Elevance Health?

    You have seen what Elevance Health is doing. Now widen your opportunity set and pressure test your thinking against other high quality ideas on Simply Wall Street.